506 related articles for article (PubMed ID: 18515791)
41. Hypertension and progression of experimental nephritis. Interaction between immunological and haemodynamic factors.
Tikkanen I; Miettinen A; Törnroth T; Fyhrquist F
Scand J Urol Nephrol Suppl; 1985; 90():45-50. PubMed ID: 3912983
[TBL] [Abstract][Full Text] [Related]
42. Mineralocorticoid regulation of cyclooxygenase-2 expression in rat renal medulla.
Zhang MZ; Hao CM; Breyer MD; Harris RC; McKanna JA
Am J Physiol Renal Physiol; 2002 Sep; 283(3):F509-16. PubMed ID: 12167602
[TBL] [Abstract][Full Text] [Related]
43. Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo.
Queisser N; Amann K; Hey V; Habib SL; Schupp N
Free Radic Biol Med; 2013 Jan; 54():17-25. PubMed ID: 23104102
[TBL] [Abstract][Full Text] [Related]
44. Histometric assessment of renal arterioles during DOCA and post-DOCA hypertension and hydralazine treatment in rats.
Vial JH; Boyd GW
J Hypertens; 1989 Mar; 7(3):203-9. PubMed ID: 2708816
[TBL] [Abstract][Full Text] [Related]
45. Grape seed proanthocyanidins prevent DOCA-salt hypertension-induced renal injury and its mechanisms in rats.
Lan CZ; Ding L; Su YL; Guo K; Wang L; Kan HW; Ou YR; Gao S
Food Funct; 2015 Jul; 6(7):2179-86. PubMed ID: 26011796
[TBL] [Abstract][Full Text] [Related]
46. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
[TBL] [Abstract][Full Text] [Related]
47. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
Brilla CG; Weber KT
J Lab Clin Med; 1992 Dec; 120(6):893-901. PubMed ID: 1453111
[TBL] [Abstract][Full Text] [Related]
48. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG
Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306
[TBL] [Abstract][Full Text] [Related]
49. Contribution of central nitric oxide to the regulation of blood pressure and sodium balance in DOCA-salt hypertension.
Seto S; Nagao S; Ozeki S; Tetsuo H; Akahoshi M; Yano K
J Cardiovasc Pharmacol; 2006 May; 47(5):680-5. PubMed ID: 16775508
[TBL] [Abstract][Full Text] [Related]
50. Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats.
Robin S; Maupoil V; Laurant P; Jacqueson A; Berthelot A
Br J Nutr; 2004 Jun; 91(6):857-65. PubMed ID: 15182389
[TBL] [Abstract][Full Text] [Related]
51. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice.
Li Y; Chakraborty A; Broughton BRS; Ferens D; Widdop RE; Ricardo SD; Samuel CS
Biomed Pharmacother; 2021 Dec; 144():112256. PubMed ID: 34607108
[TBL] [Abstract][Full Text] [Related]
52. Sex-specific effects of spironolactone on blood pressure in gonadectomized male and female Wistar rats.
Michaelis M; Hofmann PJ; Götz F; Bartel C; Kienitz T; Quinkler M
Horm Metab Res; 2012 Apr; 44(4):291-5. PubMed ID: 22266825
[TBL] [Abstract][Full Text] [Related]
53. DOCA stimulates salt appetite in Zucker rats: effect of dose, synergistic action with central angiotensin II, and obesity.
Omouessi ST; Falconetti C; Fernette B; Thornton SN
Brain Res Bull; 2007 Sep; 74(1-3):14-20. PubMed ID: 17683784
[TBL] [Abstract][Full Text] [Related]
54. Renoprotective effects of sildenafil in DOCA-salt hypertensive rats.
Bae EH; Kim IJ; Joo SY; Kim EY; Kim CS; Choi JS; Ma SK; Kim SH; Lee JU; Kim SW
Kidney Blood Press Res; 2012; 36(1):248-57. PubMed ID: 23171857
[TBL] [Abstract][Full Text] [Related]
55. Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte/macrophage infiltration in the heart of DOCA/salt hypertensive rats.
Ishimaru K; Ueno H; Kagitani S; Takabayashi D; Takata M; Inoue H
J Cardiovasc Pharmacol; 2007 Aug; 50(2):187-94. PubMed ID: 17703135
[TBL] [Abstract][Full Text] [Related]
56. Enhanced hypotensive effects of the essential oil of Ocimum gratissimum leaves and its main constituent, eugenol, in DOCA-salt hypertensive conscious rats.
Interaminense LF; Leal-Cardoso JH; Magalhães PJ; Duarte GP; Lahlou S
Planta Med; 2005 Apr; 71(4):376-8. PubMed ID: 15856420
[TBL] [Abstract][Full Text] [Related]
57. Beneficial effects of angiotensin-(1-7) against deoxycorticosterone acetate-induced diastolic dysfunction occur independently of changes in blood pressure.
de Almeida PW; Melo MB; Lima Rde F; Gavioli M; Santiago NM; Greco L; Jesus IC; Nocchi E; Parreira A; Alves MN; Mitraud L; Resende RR; Campagnole-Santos MJ; Dos Santos RA; Guatimosim S
Hypertension; 2015 Aug; 66(2):389-95. PubMed ID: 26077567
[TBL] [Abstract][Full Text] [Related]
58. Renal Inflammation in DOCA-Salt Hypertension.
Banek CT; Gauthier MM; Van Helden DA; Fink GD; Osborn JW
Hypertension; 2019 May; 73(5):1079-1086. PubMed ID: 30879356
[TBL] [Abstract][Full Text] [Related]
59. Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats.
Bae EH; Kim IJ; Park JW; Ma SK; Lee JU; Kim SW
Nephrol Dial Transplant; 2010 Apr; 25(4):1051-9. PubMed ID: 19948880
[TBL] [Abstract][Full Text] [Related]
60. Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans.
Williamson PM; Kelly JJ; Whitworth JA
J Hypertens Suppl; 1996 Dec; 14(5):S37-41. PubMed ID: 9120683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
